GT Biopharma, Inc.
USD0.46
+0.02 (+4.48%)
CEO
Michael Martin Breen
IPO Date
2018-03-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.44
Prev. Close
$0.44
Day Low
$0.43
Day High
$0.50
52W Low
$0.26
52W High
$3.73
Market Cap
$0.00B
Volume
0.78M
| -0.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -101.6% | -53.8% | 0.01 | 2.12 | -1.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -178.0% | -124.8% | 0.01 | 3.35 | -40.5 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -264.8% | -180.3% | 0.00 | 3.14 | -44.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 96.7% | -499.8% | -0.90 | 0.16 | -33.5 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 201.9% | -9759.3% | -0.70 | 0.01 | -3.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -2246.2% | -1020.5% | 0.94 | 0.01 | -3.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -57.2% | -56.7% | 0.00 | 0.22 | -15.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -52.1% | 39072.0% | -0.66 | 0.00 | 0.2 |
| -0.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 276.6% | 192.1% | 0.00 | 2.70 | 0.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -626.3% | -423.5% | 0.00 | 3.09 | -0.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 79.2% | -29.2% | 0.00 | 0.73 | -1.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 226.0% | -89.2% | 0.00 | 0.72 | -0.4 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -162.7% | -50.5% | 0.00 | 1.45 | -0.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -67.4% | -40.0% | 0.00 | 2.47 | -0.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -42.7% | -22.9% | 0.01 | 2.15 | -0.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -39.6% | -21.0% | 0.01 | 2.12 | -0.9 |